603229 奧翔藥業
按盤價 
11.420 +0.030 (+0.263%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.210 | 9.371 | 14.095 | 17.333 | 12.254 |
| 總資產報酬率 ROA (%) | 5.536 | 6.970 | 9.641 | 11.330 | 9.061 |
| 投入資產回報率 ROIC (%) | 6.051 | 7.874 | 11.433 | 13.573 | 10.326 | 邊際利潤分析 |
| 銷售毛利率 (%) | 58.155 | 54.233 | 55.048 | 51.501 | 54.787 |
| 營業利潤率 (%) | 40.558 | 30.322 | 35.607 | 33.708 | 28.112 |
| 息稅前利潤/營業總收入 (%) | 38.611 | 27.238 | 31.479 | 27.939 | 28.989 |
| 淨利潤/營業總收入 (%) | 35.143 | 26.002 | 31.086 | 30.786 | 25.615 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 92.293 | 91.510 | 96.382 | 98.049 | 95.144 |
| 價值變動淨收益/利潤總額(%) | 7.631 | 11.809 | 0.241 | 2.473 | 7.317 |
| 營業外收支淨額/利潤總額(%) | -0.390 | -0.393 | -0.021 | -0.725 | -0.477 | 償債能力分析 |
| 流動比率 (X) | 2.834 | 2.534 | 2.172 | 1.525 | 1.924 |
| 速動比率 (X) | 2.222 | 1.939 | 1.699 | 1.095 | 1.465 |
| 資產負債率 (%) | 22.626 | 23.823 | 27.443 | 36.893 | 31.783 |
| 帶息債務/全部投入資本 (%) | 15.433 | 14.167 | 14.951 | 20.263 | 20.519 |
| 股東權益/帶息債務 (%) | 540.458 | 596.424 | 558.661 | 384.038 | 384.451 |
| 股東權益/負債合計 (%) | 341.962 | 319.760 | 264.394 | 171.056 | 214.630 |
| 利息保障倍數 (X) | -21.578 | -9.187 | -7.639 | -5.056 | 28.669 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 88.226 | 73.551 | 58.966 | 47.334 | 35.325 |
| 存貨周轉天數 (天) | 358.399 | 378.875 | 336.194 | 273.793 | 303.018 |
| 備註： | 即時報價更新時間為 28/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
